S9-CMC1 TFA
S9-CMC1 TFA is a covalent LSD1 inhibitor (IC50=2.53 μM) targeting Cys360. It increases H3K4me1/2 levels, leading to cell cycle arrest, apoptosis, and suppressed proliferation in vitro, and demonstrates significant antitumor efficacy in A549 xenograft models in vivo for cancer research.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation
Molecular Weight
2158.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
056358-01 10 µg
Cytokeratin 18 (CK18), Recombinant, Porcine, His-Tag
Sign In for Pricing
View Details 
056358-02 50 µg
Cytokeratin 18 (CK18), Recombinant, Porcine, His-Tag
Sign In for Pricing
View Details 
056358-03 100 µg
Cytokeratin 18 (CK18), Recombinant, Porcine, His-Tag
Sign In for Pricing
View Details 056358-04 200 µg
Cytokeratin 18 (CK18), Recombinant, Porcine, His-Tag
Sign In for Pricing
View Details